Ida Aronchik

Title: The Innovative Contributions of Ida Aronchik

Introduction

Ida Aronchik is a notable inventor based in Summit, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of new therapeutic methods. His work focuses on targeting cold tumors, which has the potential to improve treatment outcomes for patients suffering from neoplastic diseases.

Latest Patents

Ida Aronchik holds a patent for "Methods of treating cancer by targeting cold tumors." This patent outlines methods for treating cancer or neoplastic diseases by administering a specific compound, 4-[2-(4-amino-piperidin-1-yl)-5-(3-fluoro-4-methoxy-phenyl)-1-methyl-6-oxo-1,6-dihydro-pyrimidin-4-yl]-2-fluoro-benzonitrile, or a pharmaceutically acceptable salt thereof. The methods described are particularly aimed at patients with neoplastic cells that express RCOR2, providing a targeted approach to cancer therapy.

Career Highlights

Ida Aronchik is associated with Celgene Corporation, a leading biopharmaceutical company known for its focus on innovative cancer therapies. His work at Celgene has allowed him to contribute to groundbreaking research that aims to enhance the effectiveness of cancer treatments.

Collaborations

Throughout his career, Ida has collaborated with esteemed colleagues, including Ellen Filvaroff and Brian Fox. These collaborations have fostered an environment of innovation and have been instrumental in advancing research in cancer treatment.

Conclusion

Ida Aronchik's contributions to cancer treatment through his patented methods demonstrate his commitment to improving patient outcomes. His work at Celgene Corporation and collaborations with other experts highlight the importance of teamwork in the field of medical research. His innovative approach to targeting cold tumors represents a significant advancement in the fight against cancer.